Suppr超能文献

在水化预防尿路结石试验中自我报告的有症状结石复发的判定

Adjudication of Self-reported Symptomatic Stone Recurrence in the Prevention of Urinary Stones With Hydration Trial.

作者信息

Wessells Hunter, Lieske John C, Lai H Henry, Al-Khalidi Hussein R, Desai Alana C, Harper Jonathan D, Kirkali Ziya, Maalouf Naim M, McCune Rebecca, Reese Peter P, Scales Charles D, Tasian Gregory E

机构信息

Department of Urology, University of Washington School of Medicine, Seattle, WA.

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.

出版信息

Urology. 2024 Dec;194:27-35. doi: 10.1016/j.urology.2024.08.026. Epub 2024 Sep 4.

Abstract

OBJECTIVE

To assess accuracy of self-reported stone events in a large clinical trial by adjudication against the weight of documentation for spontaneous stone passage or surgical intervention.

METHODS

Participants in the Prevention of Urinary Stones with Hydration (PUSH) trial were randomized to a multi-component behavioral intervention or control arm to increase and maintain high fluid intake. The primary endpoint was urinary stone events including symptomatic stone passage or procedural intervention. An independent adjudication committee blinded to randomization assignments reviewed all events. Confirmed clinical stone events required typical stone symptoms and documentation of stone passage (eg, via photograph, clinical record) and/or surgical intervention. Events with typical symptoms and self-described stone passage but without objective documentation of passage were also considered as meeting the primary endpoint and classified separately as patient-reported passage. Non-events did not meet either criteria.

RESULTS

At time of this blinded analysis, a total of 1658 participants were randomized and had a median follow-up of 19 months. Self-reported stone events (n = 217) were adjudicated by the committee as either confirmed clinical events (134; 61.8%), patient-reported passage (71; 32.7%), or non-events (12; 5.5%). Confirmed clinical events consisted of stone passage in 66/134 and procedural interventions in 68/134 (53 for symptoms and 15 without symptoms).

CONCLUSION

Rigorous adjudication revealed that self-reported stone events in the PUSH trial overwhelmingly represented clinically documented passage, surgical intervention, and patient-reported passage outside healthcare settings, with only 5.5% failing to satisfy adjudication criteria. Similar adjudication and classification processes warrant consideration for implementation in future stone trials.

CLINICAL TRIALS REGISTRATION

NCT03244189.

摘要

目的

通过对照自发性结石排出或手术干预的文档记录,评估一项大型临床试验中自我报告的结石事件的准确性。

方法

预防尿路结石水化试验(PUSH试验)的参与者被随机分配到多成分行为干预组或对照组,以增加并维持高液体摄入量。主要终点是尿路结石事件,包括有症状的结石排出或程序干预。一个对随机分组任务不知情的独立判定委员会审查了所有事件。确诊的临床结石事件需要有典型的结石症状以及结石排出的记录(如通过照片、临床记录)和/或手术干预。有典型症状且自述有结石排出但无排出客观记录的事件也被视为符合主要终点,并单独分类为患者报告的排出。非事件则不符合任何一项标准。

结果

在本次盲法分析时,共有1658名参与者被随机分组,中位随访时间为19个月。委员会将自我报告的结石事件(n = 217)判定为确诊临床事件(134例;61.8%)、患者报告的排出(71例;32.7%)或非事件(12例;5.5%)。确诊临床事件包括66/134例结石排出和68/134例程序干预(53例有症状,15例无症状)。

结论

严格判定显示,PUSH试验中自我报告的结石事件绝大多数代表临床记录的排出、手术干预以及患者报告的医疗机构疗的医疗环境外的排出,只有5.5%不符合判定标准。未来的结石试验值得考虑采用类似的判定和分类流程。

临床试验注册

NCT03244189。

相似文献

8
Alpha-blockers as medical expulsive therapy for ureteral stones.α受体阻滞剂作为输尿管结石的药物排石疗法
Cochrane Database Syst Rev. 2018 Apr 5;4(4):CD008509. doi: 10.1002/14651858.CD008509.pub3.
9
Tamoxifen for adults with hepatocellular carcinoma.他莫昔芬治疗肝细胞癌成人患者。
Cochrane Database Syst Rev. 2024 Aug 12;8(8):CD014869. doi: 10.1002/14651858.CD014869.pub2.
10
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.

本文引用的文献

4
Determining the true burden of kidney stone disease.确定肾结石疾病的真实负担。
Nat Rev Nephrol. 2020 Dec;16(12):736-746. doi: 10.1038/s41581-020-0320-7. Epub 2020 Aug 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验